Metoprolol Succinate Tablet, Extended Release
Product Images NDC 51655-919

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 51655-919). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

51655-919-26 (51655 919 26 Rev A 04 23)

51655-919-26 (51655 919 26 Rev A 04 23)
Label for Metoprolol succinate Extended-Release Tablets USP 50 mg, bottle of 90 tablets. The label includes NDC 51655-919-26, storage instructions, and manufacturer information for Northwind Pharmaceuticals, LLC. It specifies Rx only and gives details on tablet composition and repackaging.*
FDA Label Image

Picture-1 (Picture 1)

Picture-1 (Picture 1)
A forest plot showing results for subgroups in the MERIT-HF study. It compares metoprolol succinate extended release tablets versus placebo for three outcomes: total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure. The plot includes subgroup analyses by geography, NYHA class, ejection fraction, etiology, sex, race, medical history, diabetes status, hypertension, and heart rate, with relative risk and 95% confidence intervals displayed.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of metoprolol succinate, showing its molecular components and arrangement, including the methoxy and hydroxyl groups along with the succinate moiety represented on the right side of the structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.